EVOLVE-AF PCI (registration number 4810638) is a United States trademark of DAIICHI SANKYO COMPANY, LIMITED. The goods and services are: Providing medical information in the field of pharmaceutical preparations; providing medical information on the efficacy, side effects, interactions or administration of pharmaceutical preparations “PCI” Conducting of clinical studies and trials of pharmaceuticals; providing information on clinical studies and trials of pharmaceuticals. The correspondent is Mark Lebow.
This trademark was filed on July 08, 2014 as United States Trademark Application Serial Number 79156127.
Trademark PTO Status
20220703 – NEW REPRESENTATIVE AT IB RECEIVED
20220401 – CANCELLED SECTION 71
20200915 – COURTESY REMINDER – SEC. 71 (6-YR) E-MAILED
20160527 – FINAL DECISION TRANSACTION PROCESSED BY IB
20160319 – FINAL DISPOSITION NOTICE SENT TO IB
20160319 – FINAL DISPOSITION PROCESSED
20151215 – FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20150915 – REGISTERED-PRINCIPAL REGISTER
Ownership History
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
DAIICHI SANKYO COMPANY, LIMITED
File a Trademark
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.